6550
北極星藥業-KY
-0.23 (-2.25%)9.972,215成交張數–本益比1.97股價淨值比0.00%殖利率2026-09-11資料日期
每股盈餘
柱為單季 EPS,線為近四季合計;近十年
| 季度 | 單季 EPS | 年增 | 近四季 EPS | 歸屬母公司淨利(億) | 淨利率 | ROE(季) | ROE(近四季) |
|---|---|---|---|---|---|---|---|
| 2026Q2 | -0.98 | – | -4.70 | -8.47 | -11947.3% | -18.14% | -81.61% |
| 2026Q1 | -0.64 | – | -4.88 | -5.54 | -1493.0% | -10.97% | -69.74% |
| 2025Q4 | -2.19 | – | -5.10 | -16.82 | -27944.0% | -35.46% | -65.50% |
| 2025Q3 | -0.89 | – | -4.03 | -6.86 | -3865.0% | -15.44% | -60.16% |
| 2025Q2 | -1.16 | – | -4.11 | -8.94 | -10630.1% | -16.49% | -53.95% |
| 2025Q1 | -0.86 | – | -3.68 | -6.66 | -7899.7% | -10.37% | -41.39% |
| 2024Q4 | -1.12 | – | -3.35 | -8.44 | -2328.3% | -13.21% | -35.60% |
| 2024Q3 | -0.97 | – | -2.96 | -7.18 | -6562.9% | -11.08% | -30.95% |
| 2024Q2 | -0.73 | – | -2.56 | -5.50 | -1716.9% | -7.78% | -25.22% |
| 2024Q1 | -0.53 | – | -2.28 | -3.91 | -1407.4% | -5.33% | -21.57% |
| 2023Q4 | -0.73 | – | -2.12 | -5.44 | -11106.8% | -7.01% | -19.66% |
| 2023Q3 | -0.57 | – | -1.78 | -4.25 | -52618.8% | -5.18% | -15.25% |
| 2023Q2 | -0.45 | – | – | -3.33 | -20559.1% | -3.99% | – |
| 2023Q1 | -0.37 | – | – | -2.74 | -180227.0% | -3.20% | – |
| 2022Q4 | -0.39 | – | – | -2.89 | -31381.6% | -3.24% | – |
| 2022Q3 | -0.41 | – | – | -3.06 | -87724.6% | – | – |